Allurion Technologies announced further expansion of its Virtual Care Suite VCS digital platform with new commercial agreements signed with Lazeo, France’s largest aesthetic and weight loss clinic chain, and Transform, UK’s largest aesthetic and weight loss clinic chain. After recently expanding its commercial agreement with Weight Doctors -Germany’s leading group of private clinics and centers for weight loss-Allurion believes that the accelerated expansion of VCS through key partnerships underscores the growing number of opportunities for the digital platform since launching Coach Iris-Allurion’s 24/7 AI-powered weight loss coach-in October 2023. The Allurion Virtual Care Suite is a comprehensive set of tools designed to power any weight loss practice: in an Allurion study, 87% of providers who use the VCS report increased patient accountability, 88% report increased efficiencies in their practice, and 82% report increased patient engagement. Clinics with the highest VCS usage rate achieve on average 11% additional weight loss, with over 16% additional patients reaching their goals. With the launch of Coach Iris, the VCS now provides 24/7 coaching and guidance to patients across multiple modalities of care, including anti-obesity medications, devices, and bariatric surgery.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALUR:
- Allurion publishes study showing improvement in obesity-related co-morbidities
- Allurion Technologies sees FY 24 revenue $60M – $65M
- Allurion Technologies sees Q4 revenue $8.1M-$8.4M
- Allurion Technologies expands deal with Weight Doctors, hires Brian Conyer
- Allurion Technologies files to sell 9.48M shares of common stock for holders
